California has long been at the center of the mesothelioma crisis in the United States. Decades of shipbuilding along the San Francisco Bay, oil refinery work in the Central Valley, and construction booms across Los Angeles left hundreds of thousands of workers exposed to asbestos. Today, California consistently ranks among the top states for mesothelioma diagnoses, with the California Cancer Registry reporting over 2,500 new pleural mesothelioma cases diagnosed in the state between 2000 and 2020 [1]. That history is painful. But it also means California has developed some of the most specialized, well-resourced mesothelioma treatment programs in the country.
If you or someone you love has just received a mesothelioma diagnosis, the sheer amount of information coming at you right now can feel overwhelming. What I hear from patients going through this is that they want two things above all else: honest information about their options and someone to help them take the next step. This article is written with both of those goals in mind. We'll walk through where treatment is available in California, what the latest therapies look like, how clinical trials work, and what financial resources exist to help you access care.
Why Does California Have So Many Mesothelioma Cases?
Understanding the history behind California's mesothelioma burden matters, because it shapes everything from where specialized treatment centers are located to what legal resources are available to patients. California's naval shipyards, particularly Mare Island Naval Shipyard in Vallejo and the Long Beach Naval Shipyard, were among the most active asbestos-exposure sites in the country during World War II and the Cold War era [2]. Workers who insulated pipes, applied fireproofing materials, and maintained boilers in those facilities often had no idea they were breathing in fibers that would take 20 to 50 years to cause cancer.
Beyond the shipyards, California's construction industry, power plants, and schools built before 1980 used asbestos extensively in floor tiles, roofing materials, and insulation. The Libby, Montana vermiculite contamination also affected California residents who used Zonolite attic insulation in their homes [3]. All of this adds up to a population with significant latency-period exposure, meaning many Californians diagnosed today worked with asbestos decades ago and are only now seeing symptoms.
This history is one reason California has developed such robust legal protections for mesothelioma patients. The state's statute of limitations gives patients one year from the date of diagnosis, or one year from the date they reasonably should have known about the connection between their illness and asbestos exposure, to file a personal injury claim [4]. You can check the specific rules that apply to your situation using our statute of limitations tool.
:::stat 2,500+ | Mesothelioma cases diagnosed in California between 2000 and 2020:::
Where Are California's Leading Mesothelioma Treatment Centers?
Imagine being diagnosed at a community hospital that sees one or two mesothelioma cases a year versus being treated at a center that manages dozens of cases monthly. The difference in outcomes can be significant. Mesothelioma is rare enough that expertise is genuinely concentrated in a handful of institutions, and California is fortunate to have several of them.
University of California, San Francisco (UCSF). UCSF's thoracic oncology program is consistently ranked among the top programs in the country. Their multidisciplinary mesothelioma team includes thoracic surgeons, medical oncologists, radiation oncologists, and pathologists who specialize in pleural diseases. UCSF participates in multiple National Cancer Institute (NCI)-sponsored clinical trials and has particular expertise in cytoreductive surgery combined with heated intrapleural chemotherapy [5].
Cedars-Sinai Medical Center, Los Angeles. Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute has a dedicated thoracic oncology program that treats both pleural and peritoneal mesothelioma. Their team has published research on immunotherapy combinations for mesothelioma and participates in cooperative group trials through the NCI's National Clinical Trials Network [5].
UC San Diego Moores Cancer Center. As an NCI-designated comprehensive cancer center, Moores offers access to early-phase clinical trials and has surgical expertise in extended pleurectomy/decortication (EPD), a lung-sparing surgery increasingly preferred over the more aggressive extrapleural pneumonectomy (EPP) for eligible patients [6].
Stanford Cancer Institute. Stanford's program emphasizes translational research, meaning they move laboratory discoveries into clinical practice relatively quickly. Their immunotherapy research has contributed to several trials now available to mesothelioma patients nationwide [5].
Beyond these flagship institutions, City of Hope in Duarte, UCLA's Jonsson Comprehensive Cancer Center, and USC Norris Comprehensive Cancer Center all offer mesothelioma-specific care. The key is finding a center where mesothelioma is not an afterthought but a genuine area of clinical focus. Our diagnosis and treatment resource guide can help you evaluate your options and prepare the right questions before your first specialist appointment.
What Treatment Options Are Available for Mesothelioma Patients in California?
Mesothelioma treatment has changed considerably over the past five years, and California centers are at the forefront of that evolution. Treatment decisions depend on your specific diagnosis: the cell type (epithelioid, sarcomatoid, or biphasic), the stage of disease, where the tumor is located (pleural versus peritoneal versus pericardial), and your overall health and performance status.
Surgery. For patients with early-stage pleural mesothelioma and good performance status, surgery remains a core component of multimodal treatment. The two primary surgical approaches are extrapleural pneumonectomy (EPP), which removes the affected lung along with the pleura, and pleurectomy/decortication (P/D or EPD), which removes the pleura while preserving the lung. A 2021 analysis published in the Journal of Thoracic Oncology found that P/D was associated with lower 30-day mortality than EPP while achieving comparable survival outcomes in selected patients [6]. California's top centers now generally favor P/D when surgically feasible.
Chemotherapy. For decades, the standard first-line chemotherapy regimen for mesothelioma was pemetrexed combined with cisplatin or carboplatin. This combination, approved by the FDA in 2004, remained the backbone of treatment for nearly 17 years [7]. Our mesothelioma chemotherapy encyclopedia covers the full range of agents used today, including what to expect during treatment and how side effects are typically managed.
Immunotherapy. The landscape shifted dramatically in October 2020 when the FDA approved nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for unresectable pleural mesothelioma [8]. This approval was based on the CheckMate 743 trial, which enrolled 605 patients and showed that the immunotherapy combination improved median overall survival to 18.1 months compared to 14.1 months for chemotherapy alone, a statistically significant benefit particularly pronounced in patients with non-epithelioid histology [8]. California centers were among the trial's participating sites, and many now offer this combination as a standard first-line option. You can learn more about how immunotherapy works and what patients experience through our immunotherapy overview.
HIPEC for Peritoneal Mesothelioma. Patients with peritoneal mesothelioma (mesothelioma of the abdominal lining) have benefited from a specialized surgical approach called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, or HIPEC. A landmark study published in the Journal of Clinical Oncology found that patients with peritoneal mesothelioma who underwent CRS/HIPEC achieved a median overall survival of 53 months, compared to far shorter survival with systemic chemotherapy alone [9]. UCSF and Cedars-Sinai both have HIPEC programs.
:::stat 18.1 | Months median overall survival with nivolumab plus ipilimumab in CheckMate 743:::
:::quote "The most important step you can take right now is getting a second opinion at a mesothelioma specialty center. A community oncologist sees one or two of these cases a year. A specialist sees dozens. That difference shows up in the treatment plan." | Yvette Abrego, Patient Advocate:::
What Clinical Trials Are Open to California Mesothelioma Patients?
Clinical trials represent one of the most meaningful ways patients can access treatments not yet widely available, and California's NCI-designated cancer centers are among the most active trial sites in the country. As of early 2025, ClinicalTrials.gov lists more than 40 open mesothelioma trials with at least one California site [10].
Several directions in mesothelioma research are particularly active right now. CAR-T cell therapy, which engineers a patient's own immune cells to target mesothelioma-specific antigens, is being studied at sites including UCSF and City of Hope. A Phase I trial of mesothelin-targeted CAR-T cells reported promising early signals in a 2023 publication in the Journal of Clinical Oncology, with 2 of 9 evaluable patients achieving partial responses [11].
Anti-VEGF therapies combined with immunotherapy are also under investigation. Bevacizumab (Avastin), which targets the vascular endothelial growth factor pathway, has shown some benefit when added to chemotherapy in European trials, and California centers are exploring combinations with checkpoint inhibitors [12].
For patients who have progressed on first-line therapy, the DREAM3R trial (NCT04334759) is evaluating durvalumab plus olaparib versus durvalumab alone as second-line treatment, with multiple U.S. sites including California institutions [10]. Asking your oncologist specifically whether you qualify for any open trials is one of the most concrete steps you can take after your initial diagnosis.
Many patients I've worked with are surprised to learn that clinical trial participation often comes with financial support for travel and lodging. Trial sponsors typically cover the cost of the investigational drug itself, and some programs offer navigator services to help patients from rural California access urban trial sites.
:::quote "What I hear from patients going through this is that they assume clinical trials are a last resort. That's outdated thinking. In mesothelioma, a trial might actually be your best first option." | Yvette Abrego, Patient Advocate:::
How Does a Mesothelioma Diagnosis Affect Veterans in California?
California has one of the largest veteran populations in the United States, with approximately 1.6 million veterans living in the state as of 2023 [13]. Given the concentration of naval activity in California during the mid-20th century, a significant proportion of mesothelioma patients in the state are veterans who were exposed to asbestos during their military service.
The Department of Veterans Affairs (VA) provides mesothelioma care at several California facilities, including the VA San Diego Healthcare System, the San Francisco VA Medical Center, and the VA Greater Los Angeles Healthcare System. Veterans with service-connected mesothelioma are entitled to VA healthcare and disability compensation, and the VA's mesothelioma-specific rating system typically results in a 100% disability rating given the severity and prognosis of the disease [14].
Navigating VA benefits while simultaneously managing a cancer diagnosis is genuinely difficult. Our VA benefits eligibility tool can help you quickly assess what you may qualify for and what documentation you'll need. Many California veterans are also eligible to file both VA claims and civil asbestos litigation, since these two avenues are not mutually exclusive.
What Financial Resources Exist for California Mesothelioma Patients?
One of the most consistent concerns I hear from patients and their families is about cost. Mesothelioma treatment is expensive. A single cycle of nivolumab plus ipilimumab can cost tens of thousands of dollars, and surgical procedures at major centers can exceed $100,000. The financial burden is real, and it's compounded by lost income and caregiving costs.
The good news is that California patients have access to multiple layers of financial support, and understanding them together matters more than knowing about any single one in isolation.
Asbestos Trust Funds. More than 60 asbestos manufacturers and distributors have established bankruptcy trust funds to compensate people harmed by their products. As of 2024, these trusts collectively hold over $30 billion in assets [15]. If you were exposed to asbestos through a product made by a company that subsequently went bankrupt, you may be eligible to file a trust fund claim without going to court. Our trust fund directory helps patients identify which funds may apply to their specific exposure history.
Personal Injury and Wrongful Death Lawsuits. For companies that remain solvent, civil litigation remains a viable path. California courts have historically been favorable venues for asbestos litigation, and several specialized firms operate in the state. Settlements in mesothelioma cases have ranged from several hundred thousand dollars to multiple millions, depending on the strength of exposure evidence, the number of defendants, and the specific circumstances of the case [16].
Social Security Disability Insurance (SSDI). Mesothelioma qualifies as a compassionate allowance condition under the Social Security Administration's guidelines, which means SSDI applications are fast-tracked and typically approved within weeks rather than months [17]. This can provide a meaningful income bridge while you're in treatment.
Our comprehensive compensation overview walks through all of these options in detail, including how to document your exposure history and what to expect from the claims process.
:::quote "Many patients and families I've worked with don't realize they can pursue trust fund claims, VA benefits, and Social Security disability all at the same time. These are separate systems, and accessing one doesn't disqualify you from another." | Yvette Abrego, Patient Advocate:::
How Can Patients and Families Find Emotional Support During Treatment?
A mesothelioma diagnosis doesn't just affect the person who receives it. It reshapes the entire family. Spouses become caregivers. Adult children take on new responsibilities. The emotional weight of a rare cancer with a challenging prognosis is something that statistics don't capture, but it's something that every family navigating this disease knows deeply.
California has a strong network of cancer support resources. The Cancer Support Community has chapters in Los Angeles, San Francisco, and San Diego that offer free support groups, educational programs, and individual counseling for people with cancer and their families. The Mesothelioma Applied Research Foundation (MARF) connects patients with peer support volunteers, many of whom are long-term mesothelioma survivors [18].
Online communities have also become genuinely valuable, particularly for patients in rural parts of California who don't have easy access to in-person support. Our resources for patients and families section includes vetted support organizations, caregiver guides, and tools for navigating difficult conversations with loved ones.
For families who have lost someone to mesothelioma, the grief is layered with practical questions about legal options and financial security. Our answers for families resource addresses both the emotional and practical dimensions of that experience.
What Should You Do Immediately After a Mesothelioma Diagnosis in California?
Receiving a mesothelioma diagnosis is a moment that divides life into before and after. In the days that follow, it can be hard to know where to start. Based on what I've seen patients navigate, there are a few concrete steps that consistently make the biggest difference.
First, request your full pathology report and ask for it in writing. Mesothelioma is frequently misdiagnosed, and confirming your cell type (epithelioid, sarcomatoid, or biphasic) is critical because it directly affects which treatments are most likely to help you [19]. Epithelioid mesothelioma generally responds better to both surgery and immunotherapy than sarcomatoid disease.
Second, seek a second opinion at one of California's specialty centers before committing to a treatment plan. This is not disloyal to your current oncologist. It's a standard and expected part of managing a rare cancer. Many California patients have discovered through second opinions that they were surgical candidates when their initial physician thought they were not, or that a clinical trial was available that hadn't been mentioned.
Third, begin documenting your asbestos exposure history as thoroughly as you can. Write down every job you held, every worksite where you may have encountered asbestos, every product you used or installed. This documentation matters both for your medical team (understanding exposure history helps with diagnosis) and for any legal or compensation process you may pursue.
Fourth, connect with a patient advocate or mesothelioma navigator early. Many of California's major cancer centers have dedicated thoracic oncology nurse navigators who can help coordinate your care across multiple specialists. If your center doesn't offer this, organizations like MARF provide free patient support services nationally.
The most important step you can take right now is not to wait. Mesothelioma moves quickly, and the window for certain treatment options, particularly surgery, can narrow over time. But with the right team and the right information, many California patients are living longer and with better quality of life than they expected when they first heard their diagnosis.
What This Means for Patients and Families
California's mesothelioma patients face a disease with a difficult prognosis, but they also have access to some of the most advanced treatment programs, the most active clinical trial networks, and some of the strongest legal and financial protections of any patients in the country. That combination matters.
The treatment landscape has genuinely improved. The FDA approval of nivolumab plus ipilimumab in 2020 gave patients with unresectable disease a first-line option that outperforms chemotherapy alone [8]. Surgical techniques have become more refined and less morbid. CAR-T and other cellular therapies are moving through early trials with promising early signals [11]. None of this is a guarantee, but it represents real progress.
For families supporting a loved one through mesothelioma, the practical steps are as important as the medical ones. Understanding your financial options, including trust funds, VA benefits, and civil litigation, can reduce the economic pressure that compounds an already devastating situation. Connecting with a support community can reduce the isolation that many mesothelioma families describe.
You don't have to navigate this alone. California's network of specialists, advocates, and support organizations exists precisely to help patients and families find their footing after a diagnosis that feels, at first, like it takes the ground out from under you. Start with one step. Ask for a second opinion. Call a patient navigator. Use the tools in this article to understand your options. Each step forward matters.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider for guidance specific to your situation.
